Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE

BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM

Standard Dose
0.4%;0.3%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE is listed in Drugs@FDA under application 211039 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.4%;0.3% Sponsor BAUSCH LOMB IRELAND Submission history Latest submission status date: 2020-03-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE is listed in Drugs@FDA under application 211039 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.4%;0.3% Sponsor BAUSCH LOMB IRELAND Submission history Latest submission status date: 2020-03-09 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.